Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - OTHER CURRENT ASSETS
Other Current Assets CRVS - Corvus Pharmaceuticals, Inc.
744 K
LAST VALUE
-24.98%
2 YEAR CAGR
2.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR